Literature DB >> 15634925

Abnormal Th1 cell differentiation and IFN-gamma production in T lymphocytes from motheaten viable mice mutant for Src homology 2 domain-containing protein tyrosine phosphatase-1.

Wen-Mei Yu1, Siying Wang, Achsah D Keegan, Mark S Williams, Cheng-Kui Qu.   

Abstract

Src homology 2 domain-containing protein tyrosine phosphatase-1 (SHP-1) plays an important role in T and B lymphocyte signaling; however, the function of SHP-1 in Th cell differentiation, in particular, the Th1 response, has not been defined. In this study, we provide evidence that SHP-1 phosphatase negatively regulates Th1 cell development and IFN-gamma production. Compared with the wild-type control, anti-CD3-activated mouse T lymphocytes carrying the motheaten viable mutation in the SHP-1 gene produced a significantly increased amount of IFN-gamma in the presence of IL-12. This increase was also seen at the basal level without IL-12 addition. Similarly, Th1 cell differentiation and proliferation of anti-CD3-activated SHP-1 mutant lymph node cells in the presence or absence of IL-12 were markedly enhanced, indicating a negative role for SHP-1 phosphatase in such lymphocyte activities. Interestingly, IL-12-induced activation of Jak2 and STAT4, critical components for IL-12-mediated cellular responses, was shortened or attenuated in mutant T cells. Together these results suggest that SHP-1 negatively regulates Th1 cell development and functions through a mechanism that is not directly related to IL-12 signaling.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15634925     DOI: 10.4049/jimmunol.174.2.1013

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Overexpression of CD45RA isoforms in carriers of the C77G mutation leads to hyporeactivity of CD4+CD25highFoxp3+ regulatory T cells.

Authors:  C Pokoyski; T Lienen; S Rother; E Schock; A Plege-Fleck; R Geffers; R Schwinzer
Journal:  Genes Immun       Date:  2015-09-10       Impact factor: 2.676

2.  Androgens alter T-cell immunity by inhibiting T-helper 1 differentiation.

Authors:  Haydn T Kissick; Martin G Sanda; Laura K Dunn; Kathryn L Pellegrini; Seung T On; Jonathan K Noel; Mohamed S Arredouani
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-23       Impact factor: 11.205

3.  Novel SHP-1 inhibitors tyrosine phosphatase inhibitor-1 and analogs with preclinical anti-tumor activities as tolerated oral agents.

Authors:  Suman Kundu; Keke Fan; Mingli Cao; Daniel J Lindner; Zhizhaung Joe Zhao; Ernest Borden; Taolin Yi
Journal:  J Immunol       Date:  2010-04-26       Impact factor: 5.422

4.  Receptor-stimulated oxidation of SHP-2 promotes T-cell adhesion through SLP-76-ADAP.

Authors:  Jaeyul Kwon; Cheng-Kui Qu; Jin-Soo Maeng; Rustom Falahati; Chunghee Lee; Mark S Williams
Journal:  EMBO J       Date:  2005-06-02       Impact factor: 11.598

Review 5.  SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels.

Authors:  Ulrike Lorenz
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

6.  Interferon-gamma is induced in human peripheral blood immune cells in vitro by sodium stibogluconate/interleukin-2 and mediates its antitumor activity in vivo.

Authors:  Keke Fan; Ernest Borden; Taolin Yi
Journal:  J Interferon Cytokine Res       Date:  2009-08       Impact factor: 2.607

Review 7.  The role and target potential of protein tyrosine phosphatases in cancer.

Authors:  Taolin Yi; Daniel Lindner
Journal:  Curr Oncol Rep       Date:  2008-03       Impact factor: 5.075

8.  Downmodulation of Effector Functions in NK Cells upon Toxoplasma gondii Infection.

Authors:  M Afifa Sultana; Ann Du; Berit Carow; Catrine M Angbjär; Jessica M Weidner; Sachie Kanatani; Jonas M Fuks; Tamara Muliaditan; Jaime James; Imogen O Mansfield; Tessa M Campbell; Lifeng Liu; Nadir Kadri; Henrik Lambert; Antonio Barragan; Benedict J Chambers
Journal:  Infect Immun       Date:  2017-09-20       Impact factor: 3.441

Review 9.  Protein tyrosine phosphatase SHP-1: resurgence as new drug target for human autoimmune disorders.

Authors:  Yadhu Sharma; Samina Bashir; Puja Bhardwaj; Altaf Ahmad; Farah Khan
Journal:  Immunol Res       Date:  2016-08       Impact factor: 2.829

10.  Shp1 regulates T cell homeostasis by limiting IL-4 signals.

Authors:  Dylan J Johnson; Lily I Pao; Salim Dhanji; Kiichi Murakami; Pamela S Ohashi; Benjamin G Neel
Journal:  J Exp Med       Date:  2013-07-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.